Peripheral Arterial Disease

Clinical Trial Finder

Many patients with peripheral arterial disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

The Role of Percutaneous Angioplasty in Ischemic Leg Ulcer Healing

Condition:   Ischemic Foot Ulcers
Intervention:   Procedure: Percutaneous transluminal angioplasty (PTA)
Sponsor:   University of Crete
Completed - verified February 2017

OEIS Outcome Data Registry

Condition:   Peripheral Arterial Disease
Intervention:  
Sponsors:   Outpatient Endovascular and Interventional Society;   Syntactx
Recruiting - verified February 2017

Influence of Statins in Artery Aneurysms

Conditions:   Statin;   Aneurysm;   Extracellular Matrix Alteration
Intervention:   Procedure: Open Surgical Treatment of Aneurysm (Aneurysmectomy)
Sponsor:   University of Cantanzaro
Recruiting - verified February 2017

Humacyte Human Acellular Vessel (HAV) in Patients With Limb-threatening Peripheral Arterial Trauma

Condition:   Peripheral Arterial Trauma
Intervention:   Biological: Human Acellular Vessel (HAV)
Sponsors:   Humacyte, Inc.;   Atlantic Research Group;   U.S. Army Medical Research and Materiel Command
Not yet recruiting - verified February 2017

Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)

Condition:   Peripheral Arterial Disease
Interventions:   Device: Shockwave Lithoplasty® Peripheral Lithoplasty System;   Drug: Medtronic IN.PACT (DCB)
Sponsor:   Shockwave Medical, Inc.
Not yet recruiting - verified February 2017

Safety and Feasibility of the Shockwave Lithoplasty® System for the Treatment of Peripheral Vascular Stenosis

Condition:   Peripheral Arterial Disease
Intervention:   Device: Shockwave Lithoplasty® System
Sponsor:   Shockwave Medical, Inc.
Recruiting - verified February 2017

The Effects of Exercise in Patients With Systemic Sclerosis

Conditions:   Systemic Sclerosis;   Raynaud's Phenomenon;   Quality of Life
Interventions:   Other: Exercise intervention - Cycling;   Other: Exercise intervention - arm cranking
Sponsors:   Sheffield Hallam University;   Sheffield Teaching Hospitals NHS Foundation Trust
Recruiting - verified February 2017

Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD

Condition:   Peripheral Artery Disease
Intervention:   Biological: Human Acellular Vessel (HAV)
Sponsors:   Humacyte, Inc.;   Atlantic Research Group
Recruiting - verified February 2017

Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )

Conditions:   Post Thrombotic Syndrome;   Venous Thromboembolism;   Cardiovascular Diseases
Interventions:   Other: Villalta phone score > or = to 5;   Other: Villalta phone score < 5
Sponsors:   Association des Médecins Vasculaires Hospitaliers;   Daiichi Sankyo Inc.;   Ministry of Health, France;   LEO Pharma;   Sanofi;   University Hospital, Grenoble
Not yet recruiting - verified February 2017

Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM)

Conditions:   Femoral Artery Stenosis;   Popliteal Artery Stenosis;   Femoral Artery Occlusion;   Popliteal Artery Occlusion
Intervention:   Procedure: Lutonix035 Drug Coated Balloon PTA Catheter
Sponsor:   C. R. Bard
Active, not recruiting - verified February 2017

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Condition:   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Colorado Prevention Center
Recruiting - verified February 2017

Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule

Conditions:   Peripheral Arterial Disease;   Intermittent Claudication
Interventions:   Drug: Danshen Gegen Capsule;   Drug: Placebo
Sponsor:   Chinese University of Hong Kong
Recruiting - verified February 2017

Evaluation of the Tissue Genesis® Icellator Cell Isolation System™ to Treat Critical Limb Ischemia

Condition:   Critical Limb Ischemia
Intervention:   Device: TGI SVF material via intramuscular injection
Sponsors:   Tissue Genesis, LLC;   U.S. Army Medical Research and Materiel Command
Recruiting - verified February 2017

Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU

Conditions:   Peripheral Arterial Disease;   Diabetic Foot
Interventions:   Biological: 3 x 10^6 cells;   Biological: 10 x 10^6 cells;   Biological: 30 x 10^6 cells;   Biological: 100 x 10^6 cells
Sponsor:   Celgene
Completed - verified February 2017

Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)

Condition:   Peripheral Arterial Disease
Interventions:   Behavioral: Supervised Treadmill Exercise Therapy;   Other: Health education sessions (Control);   Drug: granulocyte macrophage colony stimulating factor (GM-CSF)
Sponsors:   Northwestern University;   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified February 2017